Male sex adversely affects the phenotypic expression of diabetic heart disease.

Therapeutic Advances in Endocrinology and Metabolism
Lavanya AthithanGerry P McCann

Abstract

Type 2 diabetes (T2D) is associated with an increased risk of heart failure (HF) and cardiovascular mortality. A large-scale meta-analysis on HF found that diabetes was more frequent in women than men, and diabetes appeared to have attenuated the otherwise protective effect of female sex on progression of cardiomyopathy. The exact underlying mechanisms for this remain unclear. Here, we aimed to determine the effect of sex on the phenotypic expression of diabetic heart disease in patients with T2D. A total of 62 male [mean age 44 ± 8 years, body mass index (BMI) 33 ± 5 kg/m2, mean HBA1c of 7.8 ± 1.8%] and 67 female (44 ± 10 years, BMI 35 ± 6 kg/m2, HBA1c 7.6 ± 1.2%) T2D patients on oral glucose-lowering treatment, and 16 male (48 ± 17 years, BMI 25 ± 3 kg/m2) and 14 female (50 ± 10 years, BMI 25 ± 4 kg/m2) controls were recruited. Left ventricular (LV) volumes, mass, function and deformation, and left atrial (LA) volumes and function were assessed using cardiac magnetic resonance imaging (CMR). Participants in all groups were of similar age, and there were no significant differences in blood pressure (BP), diabetes duration or metabolic profile between the two diabetes groups. Concentric remodeling was present in both sexes (p <...Continue Reading

References

Apr 10, 2002·Circulation·Heinrich TaegtmeyerMartin E Young
Oct 24, 2002·Journal of the American College of Cardiology·Andrea RossiMaurice Enriquez-Sarano
Jun 24, 2006·Journal of Magnetic Resonance Imaging : JMRI·Lucy E HudsmithStefan Neubauer
Oct 12, 2010·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Laura ErnandeGeneviève Derumeaux
Mar 10, 2012·European Journal of Heart Failure·Manuel Martínez-SellésUNKNOWN Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC)
May 28, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Akio MonjiToyoaki Murohara
Dec 19, 2013·Circulation·Sumeet S ChughChristopher J L Murray
Jul 17, 2014·European Radiology·Bruno GraçaFilipe Caseiro-Alves
Nov 19, 2014·Clinical Cardiology·Marijana Tadic, Cesare Cuspidi
Jul 2, 2016·Journal of the American College of Cardiology·Eylem LeveltStefan Neubauer
Feb 16, 2017·Circulation. Cardiovascular Imaging·Rohan S WijesurendraStefan Neubauer

❮ Previous
Next ❯

Citations

Jun 24, 2021·Cardiovascular Diabetology·Lorenzo NestiAndrea Natali

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Software Mentioned

Prism
SPSS Statistics

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.